Certificate of Analysis
|Precautionary statements||P261-P305 + P351 + P338|
|Personal Protective Equipment||dust mask type N95 (US), Eyeshields, Gloves|
|Hazard Codes (Europe)||Xi|
|Risk Statements (Europe)||36/37/38|
|Safety Statements (Europe)||26-36|
Identification of AKN-032, a novel 2-aminopyrazine tyrosine kinase inhibitor, with significant preclinical activity in acute myeloid leukemia. Eriksson, A., et al. Biochem. Pharmacol. 80, 1507-16, (2010)
In vitro and in vivo activities of 2-aminopyrazines and 2-aminopyridines in experimental models of human African trypanosomiasis. Vodnala SK, Lundbäck T, Sjöberg B, et al. Antimicrob. Agents Chemother. 57(2), 1012-8, (2013)
Synthesis of some new anils: part 1. Reaction of 2-hydroxy-benzaldehyde and 2-hydroxynaphthaldehyde with 2-aminopyridene and 2-aminopyrazine. Asiri AM and Badahdah KO Molecules 12(8), 1796-804, (2007)
Lead generation of heat shock protein 90 inhibitors by a combination of fragment-based approach, virtual screening, and structure-based drug design. Takaaki Miura et al Bioorg. Med. Chem. Lett. 21, 5778-83, (2011)
FT-IR 1 (2), 843:C / FT-IR 2 (3), 3884:A / FT-NMR 1 (3), 406:C / IR-Spectra (3), 1377:C / IR-Spectra (2), 1200:A / NMR-Reference 2 (2), 723:A / RegBook 1 (2), 2593:J / Structure Index 1, 410:B:4
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Need larger quantities for your development, manufacturing or research applications?